Edgewise Therapeutics Inc (NASDAQ: EWTX) on Monday, plunged -4.18% from the previous trading day, before settling in for the closing price of $27.72. Within the past 52 weeks, EWTX’s price has moved between $9.00 and $38.12.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 5.36%. With a float of $62.40 million, this company’s outstanding shares have now reached $94.41 million.
The extent of productivity of a business whose workforce counts for 88 workers is very important to gauge. In terms of profitability, gross margin is 29.31%, operating margin of -6534.37%, and the pretax margin is -5519.27%.
Edgewise Therapeutics Inc (EWTX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Edgewise Therapeutics Inc is 34.10%, while institutional ownership is 74.14%. The most recent insider transaction that took place on Dec 30 ’24, was worth 2,737,470. In this transaction Chief Scientific Officer of this company sold 100,000 shares at a rate of $27.37, taking the stock ownership to the 14,863 shares. Before that another transaction happened on Dec 30 ’24, when Company’s Director proposed sale 100,000 for $28.74, making the entire transaction worth $2,874,000.
Edgewise Therapeutics Inc (EWTX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 5.36% per share during the next fiscal year.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Trading Performance Indicators
Edgewise Therapeutics Inc (EWTX) is currently performing well based on its current performance indicators. A quick ratio of 26.35 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.49, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.83 in one year’s time.
Technical Analysis of Edgewise Therapeutics Inc (EWTX)
The latest stats from [Edgewise Therapeutics Inc, EWTX] show that its last 5-days average volume of 0.73 million was inferior to 0.77 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 18.31%. Additionally, its Average True Range was 1.87.
During the past 100 days, Edgewise Therapeutics Inc’s (EWTX) raw stochastic average was set at 46.28%, which indicates a significant increase from 6.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.68% in the past 14 days, which was lower than the 93.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.72, while its 200-day Moving Average is $22.97. Now, the first resistance to watch is $27.22. This is followed by the second major resistance level at $27.87. The third major resistance level sits at $28.41. If the price goes on to break the first support level at $26.02, it is likely to go to the next support level at $25.48. Assuming the price breaks the second support level, the third support level stands at $24.83.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Key Stats
Market capitalization of the company is 2.51 billion based on 94,689K outstanding shares. Right now, sales total 0 K and income totals -100,160 K. The company made 0 K in profit during its latest quarter, and -34,130 K in sales during its previous quarter.
